The Executive and Non-Executive Directors of the Company are:

• Dr Martin Knight, Chairman
• Susan Searle, Chief Executive Officer
• Julian Smith, Chief Financial and Operations Officer
• Russ Cummings, Chief Investment Officer
• Dr Paul Atherton, Non Executive Director
• Mark Rowan, Non Executive Director
• Dr David Allen, Senior Independent Non Executive Director
• Professor Stephen Richardson, Non Executive Director

Dr Martin Knight, Chairman

Dr Martin Knight joined and became Chairman of the Group in July 2003. Martin joined Morgan Grenfell & Co Ltd in 1974, becoming a director in 1982, having responsibility for five years for Project and Export Finance. Since 1988, he has advised, worked with and served on the boards of a number of private and public companies, focusing on strategic and capital raising matters. Martin is a graduate of, and has a DPhil in History from, Oxford University. Until 31 December 2010 he was Chief Finance and Operating Officer of Imperial College London.

In March 2012, Dr Knight was recognised at the 2012 NED Awards, winning the award for AIM quoted companies. The NED Awards is sponsored by the Sunday Times and the London Stock Exhcange.

Susan Searle, Chief Executive Officer

Susan Searle joined Innovations in 1994, initially as Commercial Director and was appointed Chief Executive in January 2002.  Innovations, which is quoted on the London Stock Market, has developed a proven business model that creates, builds and invests in pioneering technologies addressing global problems in healthcare, energy and engineering. It has built a portfolio of innovative companies with potential to generate significant returns for both investors and IP originators when technologies are commercialised in large multi-billion markets.

Susan was previously employed at Montech (Australia), Signet Group, Bank of Nova Scotia and Shell Chemicals in the UK and internationally, in a variety of commercial roles. She is on the Board of several companies in which Innovations has invested including i2india, Evo Electric and Plaxica.  Susan has an MA in Chemistry from Exeter College, Oxford University.

Julian Smith, Chief Financial and Operations Officer

Julian Smith was appointed to the Group as Chief Financial and Operations Officer in January 2006.  He joined the Group from RadioScape Limited where he spent six years as Chief Financial Officer and a member of the Board of Directors.  Julian’s other previous roles include Director of Treasury Operations and Company Secretary at Metapath Software International Group (MSI), Financial Controller at MSI and nine years at Arthur Andersen.  Julian is a Chartered Accountant.  Julian currently serves on the Board of Cortexica Vision Systems, a Group technology company.  Julian has an MA in Engineering Science from Oxford University.

Russ Cummings, Chief Investment Officer

Russ Cummings joined the Group from Scottish Equity Partners Limited where as director in the Information Technology Group he was responsible for investment in high growth technology companies. Russ worked at 3i Group plc where he was a director in their UK Technology Group (and previously worked at Rolls-Royce Motors as a development engineer). Russ manages the investment portfolio and decision-making process. Russ serves on the boards of the following Group technology companies: Circassia Holdings Limited and Nexeon Limited.  Russ has a BSc in Mechanical Engineering from Imperial College.

Dr Paul Atherton, Non Executive Director

Dr Paul Atherton co-founded Queensgate Instruments and was Managing Director until its sale in March 2000. Paul is an active angel investor, focusing on nanotechnology and photonics, and is a board member of a number of companies.  Paul is a shareholder in and chairman of two Group technology companies, Nexeon Limited and Midaz Lasers Limited. Paul also sits on the board of Sussex Place Ventures and was previously a governor of the London Business School.  Paul has a PhD in Physics from Imperial College.

Mark Rowan, Non Executive Director

Mark Rowan is a partner of Comvest Limited which specialises in early stage technology investment. Mark previously worked at both JPMorgan and American International Group, Inc. where he was President of Banque AIG and in charge of European Corporate Finance.  Since 1997 Mark has concentrated on the small business sector providing advice on strategic and structural issues to a broad spectrum of companies.  Mark is a shareholder in and a director of one Group technology company, RepRegen Limited.  Mark has an MA in Economics from Cambridge University.

Dr David Allen, Senior Independent Non Executive Director

Dr David Allen was appointed as a Non-Executive Director with effect from 1 August 2008.  Dr Allen joined the Group after nearly 30 years with BP plc, one of the world's leading energy firms. During his career with BP he held various posts within the company, including five years as a main board director, and was Chief of Staff from 2000 until 2007. Dr Allen has a DPhil in Physical Chemistry from Oxford University.

Professor Stephen Richardson, Non Executive Director

Professor Richardson has had a distinguished career at Imperial College London since joining as an undergraduate in 1969 and obtaining a PhD in chemical engineering in 1975.  Prior to his current roles as Deputy Rector and, since 2008, Principal of the Faculty of Engineering, Professor Richardson was Head of the Department of Chemical Engineering and Chemical Technology, from 2001, and since 1994 has been Professor of Chemical Engineering.  His research is focused on improving safety in the oil and gas industry.